Conference Coverage: ASCO 2024 – Focus on Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Global clinical experts discuss perspectives on current treatment strategies and emerging therapies in early and advanced SCCHN
July 25, 2024
FACULTY CHAIR
Amanda Psyrri, MD, PhD
Attikon University Hospital, Chaidari, Greece
Faculty Members
Robert L. Ferris, MD, PhD
UPMC Hillman Cancer Center, Pittsburgh, PA, USA
Tanguy Seiwert, MD
Johns Hopkins School of Medicine, Baltimore, MD, USA
Robert Haddad, MD
Dana-Farber Cancer Institute, Boston, MA, USA
Paolo Bossi, MD
Humanitas Cancer Center, Milan, Italy
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
- Early and Locally Advanced SCCHN – Current Treatment Strategies and Novel Therapeutic Approaches
- Metastatic SCCHN – Focus on Chemotherapy and Targeted Therapy
- Metastatic SCCHN – Focus on Immune Therapy
- SCCHN – Learnings From Real-World Data
